AT-13387,cas:912999-49-6
(2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone
Product description
AT-13387(C24H31N3O3,409.5) is a synthetic small molecule that has been developed as a potential therapeutic agent for the treatment of cancer. It is a member of the family of histone deacetylase (HDAC) inhibitors, which are drugs that target the epigenetic machinery of cells and have been used in the treatment of various types of cancer.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
Purity | >90% |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product